Atlas Trials

Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07535567 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07535567
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2026-05-05
Primary completion
2028-12-31
Enrollment
386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.